Target intelligence / Profile preview

Cytochrome c, somatic pseudogene 42 (CYCSP42)

Target
CYCSP42
Molecular classification
Pseudogene, Other
01

Overview

Cytochrome c, somatic pseudogene 42 (CYCSP42) is a human processed pseudogene, meaning it is a DNA sequence derived from the functional cytochrome c gene (CYCS) but has acquired disabling mutations, truncations, and/or insertion sequences that prevent it from being transcribed or translated into a functional protein[4]. The human genome contains at least 49 such cytochrome c pseudogenes, generally abbreviated as HCP followed by a number for their chromosomal assignment (HCP42 in this case)[4]. Pseudogenes like CYCSP42 are not actively transcribed, do not code for a protein product, and as such do not have any molecular function, biological activity, therapeutic potential, or involvement in disease. They are remnants of gene evolution and do not serve as drug targets, disease biomarkers, or therapeutic receptors/enzyme/transporter targets[3][4][6]. CYCSP42 is thus primarily relevant in the study of genomic structure, evolution, and the potential confounding of genomic assays but has no role in active biological processes.

Other names
CYC1LP5HCP42Cytochrome C pseudogeneCytochrome c, somatic pseudogene 42Cytochrome c-1-like pseudogene 5
02

Mechanism of action

None

03

Biological functions

None (as a pseudogene, it does not have known biological function)
04

Disease associations

None (no evidence for a role in disease)

Beyond the preview

Go deeper on Cytochrome c, somatic pseudogene 42 (CYCSP42).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome c, somatic pseudogene 42 (CYCSP42).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call